CC BY-NC-ND 4.0 · Rev Bras Ortop (Sao Paulo) 2023; 58(02): 320-325
DOI: 10.1055/s-0042-1757958
Artigo Original
Joelho

Comparison of Blood Loss with the Use of Intravenous and Intraarticular Tranexamic Acid Versus Isolated Intraarticular in Primary Knee Arthroplasty[*]

Article in several languages: português | English
1   Departamento de Ortopedia e Traumatologia, Hospital Universitário de Santa Maria, Santa Maria, RS, Brasil
,
2   Departamento de Ortopedia e Traumatologia, Clínica Millenarium Multi Especialidades, Porto Alegre, RS, Brasil
,
3   Serviço P&K de Cirurgia do Joelho, Porto Alegre, RS, Brasil
,
3   Serviço P&K de Cirurgia do Joelho, Porto Alegre, RS, Brasil
,
3   Serviço P&K de Cirurgia do Joelho, Porto Alegre, RS, Brasil
› Author Affiliations
Financial Support There was no financial support from public, commercial, or non-profit sources.

Abstract

Objective The objective of this work is to compare blood loss during primary knee arthroplasty with the use of intravenous and intraarticular (IV + IA) tranexamic acid versus intraarticular (IA) tranexamic acid alone.

Methods This is a randomized, double-blind clinical trial. Patients with indication for primary total knee arthroplasty were recruited in a specialized clinic, where they were operated by the same surgeon, always using the same surgical technique. Thirty patients were allocated in the IV + IA tranexamic acid group and 30 patients in the IA tranexamic acid group, according to randomization. Blood loss was compared through hemoglobin, hematocrit, drain volume, and blood loss estimation (Gross and Nadler calculus).

Results After collection, data from 40 patients were analyzed, 22 in the IA group and 18 in the IV + IA group. There were 20 losses due to collection error. Between groups IA and IV + IA, there were no significant differences in 24 hours between hemoglobin levels (10.56 vs. 10.65 g/dL; F1.39 = 0.63, p = 0.429), erythrocyte (3.63 vs. 3.73 million/mm3; F1.39 = 0.90, p = 0.346); hematocrit (32.14 vs. 32.60%; F1.39 = 1.39, p = 0.240); drainage volume (197.0 vs. 173.6 mL; F1.39 = 3.38 p = 0.069); and estimated blood loss (1,002.5 vs. 980.1; F1.39 = 0.09, p = 0.770). The same occurred in comparisons conducted after 48 hours postoperatively. Time was a significant factor for the change of all outcome variables. However, the treatment did not modify the effect of time on these outcomes. No individual presented any thromboembolic event during the work period.

Conclusions The use of IV + IA tranexamic acid showed no advantage in reducing blood loss when compared to the use of IA tranexamic acid alone in primary knee arthroplasties. This technique proved to be safe, since no thromboembolic event occurred during the development of the work.

* Work developed at Regina Hospital, Novo Hamburgo, RS, Brazil.




Publication History

Received: 29 December 2021

Accepted: 12 September 2022

Article published online:
25 May 2023

© 2023. Sociedade Brasileira de Ortopedia e Traumatologia. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Revinter Publicações Ltda.
Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil

 
  • Referências

  • 1 Nielsen CS, Jans Ø, Ørsnes T, Foss NB, Troelsen A, Husted H. Combined Intra-Articular and Intravenous Tranexamic Acid Reduces Blood Loss in Total Knee Arthroplasty: A Randomized, Double-Blind, Placebo-Controlled Trial. J Bone Joint Surg Am 2016; 98 (10) 835-841
  • 2 Maempel JF, Wickramasinghe NR, Clement ND, Brenkel IJ, Walmsley PJ. The pre-operative levels of haemoglobin in the blood can be used to predict the risk of allogenic blood transfusion after total knee arthroplasty. Bone Joint J 2016; 98-B (04) 490-497
  • 3 Park JH, Rasouli MR, Mortazavi SM, Tokarski AT, Maltenfort MG, Parvizi J. Predictors of perioperative blood loss in total joint arthroplasty. J Bone Joint Surg Am 2013; 95 (19) 1777-1783
  • 4 Panni AS, Cerciello S, Vasso M, Del Regno C. Knee flexion after total knee arthroplasty reduces blood loss. Knee Surg Sports Traumatol Arthrosc 2014; 22 (08) 1859-1864
  • 5 da Rocha VM, de Barros AG, Naves CD. et al. Use of tranexamic acid for controlling bleeding in thoracolumbar scoliosis surgery with posterior instrumentation. Rev Bras Ortop 2015; 50 (02) 226-231
  • 6 McCormack PL. Tranexamic acid: a review of its use in the treatment of hyperfibrinolysis. Drugs 2012; 72 (05) 585-617
  • 7 Yang ZG, Chen WP, Wu LD. Effectiveness and safety of tranexamic acid in reducing blood loss in total knee arthroplasty: a meta-analysis. J Bone Joint Surg Am 2012; 94 (13) 1153-1159
  • 8 Ishida K, Tsumura N, Kitagawa A. et al. Intra-articular injection of tranexamic acid reduces not only blood loss but also knee joint swelling after total knee arthroplasty. Int Orthop 2011; 35 (11) 1639-1645
  • 9 Sabbag OD, Abdel MP, Amundson AW, Larson DR, Pagnano MW. Tranexamic Acid Was Safe in Arthroplasty Patients With a History of Venous Thromboembolism: A Matched Outcome Study. J Arthroplasty 2017; 32 (9S): S246-S250
  • 10 Wong J, Abrishami A, El Beheiry H. et al. Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial. J Bone Joint Surg Am 2010; 92 (15) 2503-2513
  • 11 Alshryda S, Mason J, Vaghela M. et al. Topical (intra-articular) tranexamic acid reduces blood loss and transfusion rates following total knee replacement: a randomized controlled trial (TRANX-K). J Bone Joint Surg Am 2013; 95 (21) 1961-1968
  • 12 Gomez-Barrena E, Ortega-Andreu M, Padilla-Eguiluz NG, Pérez-Chrzanowska H, Figueredo-Zalve R. Topical intra-articular compared with intravenous tranexamic acid to reduce blood loss in primary total knee replacement: a double-blind, randomized, controlled, noninferiority clinical trial. J Bone Joint Surg Am 2014; 96 (23) 1937-1944
  • 13 Patel JN, Spanyer JM, Smith LS, Huang J, Yakkanti MR, Malkani AL. Comparison of intravenous versus topical tranexamic acid in total knee arthroplasty: a prospective randomized study. J Arthroplasty 2014; 29 (08) 1528-1531
  • 14 Sassoon A, Nam D, Jackups R, Johnson SR, Nunley RM, Barrack RL. Tranexamic acid: optimal blood loss management in surface replacement arthroplasty. Bone Joint J 2016; 98-B (02) 173-178
  • 15 Almeida MDC, Albuquerque RPE, Palhares GM, Almeida JPC, Barretto JM, Cavanellas N. Evaluation of the use of tranexamic acid in total knee arthroplasty. Rev Bras Ortop 2018; 53 (06) 761-767
  • 16 Fillingham YA, Ramkumar DB, Jevsevar DS. et al. The Efficacy of Tranexamic Acid in Total Knee Arthroplasty: A Network Meta-Analysis. J Arthroplasty 2018; 33 (10) 3090-3098.e1
  • 17 Goes RFA, Silva AF, Lyra FS, Lourdes FB, Palma IM, Cobra HAAB. et al. Estudo prospectivo randomizado após uso de dreno na artroplastia total do joelho com implante. Rev Bras Ortop 2013; 48 (03) 257-262
  • 18 Andrade MAP, Campos TVO, Silva BFA, Assis ME, Boechat LC, Biondi LF. et al. Avaliação prospectiva dos pacientes submetidos á artroplastia total de joelho com e sem colocação de dreno de sucção. Rev Bras Ortop 2010; 45 (06) 549-553
  • 19 Leão MGS, Souza HAP, Ferreira YMC. Avaliação da perda sanguínea após a liberação precoce ou tardia da isquemia em pacientes submetidos à artroplastia total do joelho. Rev Bras Ortop 2013; 48 (02) 152-158
  • 20 Mi B, Liu G, Zhou W. et al. Intra-articular versus intravenous tranexamic acid application in total knee arthroplasty: a meta-analysis of randomized controlled trials. Arch Orthop Trauma Surg 2017; 137 (07) 997-1009
  • 21 Zhang LK, Ma JX, Kuang MJ. et al. Comparison of oral versus intravenous application of tranexamic acid in total knee and hip arthroplasty: A systematic review and meta-analysis. Int J Surg 2017; 45: 77-84
  • 22 Su EP, Su S. Strategies for reducing peri-operative blood loss in total knee arthroplasty. Bone Joint J 2016; 98-B (1, Suppl A) 98-100
  • 23 Bong MR, Patel V, Chang E, Issack PS, Hebert R, Di Cesare PE. Risks associated with blood transfusion after total knee arthroplasty. J Arthroplasty 2004; 19 (03) 281-287
  • 24 Ponnusamy KE, Kim TJ, Khanuja HS. Perioperative blood transfusions in orthopaedic surgery. J Bone Joint Surg Am 2014; 96 (21) 1836-1844
  • 25 Aguilera X, Martinez-Zapata MJ, Bosch A. et al. Efficacy and safety of fibrin glue and tranexamic acid to prevent postoperative blood loss in total knee arthroplasty: a randomized controlled clinical trial. J Bone Joint Surg Am 2013; 95 (22) 2001-2007
  • 26 Henry DA, Carless PA, Moxey AJ. et al. Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev 2011; (01) CD001886
  • 27 Zekcer A, Priori RD, Tieppo C, Silva RSD, Severino NR. Comparative study of topical vs. intravenous tranexamic acid regarding blood loss in total knee arthroplasty. Rev Bras Ortop 2017; 52 (05) 589-595
  • 28 Wang D, Wang HY, Cao C. et al. Tranexamic acid in primary total knee arthroplasty without tourniquet: a randomized, controlled trial of oral versus intravenous versus topical administration. Sci Rep 2018; 8 (01) 13579
  • 29 Zhang YM, Yang B, Sun XD, Zhang Z. Combined intravenous and intra-articular tranexamic acid administration in total knee arthroplasty for preventing blood loss and hyperfibrinolysis: A randomized controlled trial. [published correction appears in Medicine (Baltimore) 2019;98(12):e15000] Medicine (Baltimore) 2019; 98 (07) e14458
  • 30 Souza Neto EP, Usandizaga G. Comparison of two doses of intra-articular tranexamic acid on postoperative bleeding in total knee arthroplasty: a randomized clinical trial. Braz J Anesthesiol 2020; 70 (04) 318-324